Highlights Newsletter 4
This newsletter presents you the following key sessions:
4. Sotorasib in combination with pembrolizumab or atezolizumab in advanced KRASG12C NSCLC
This newsletter presents you the following key sessions:
4. Sotorasib in combination with pembrolizumab or atezolizumab in advanced KRASG12C NSCLC
Medical writer
Medical writer